Candlestick Capital Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-500,000
Closed -$68.2M 77
2024
Q2
$68.2M Buy
500,000
+175,000
+54% +$24.3M 1.88% 14
2024
Q1
$49.8M Buy
325,000
+60,000
+23% +$8.96M 1.03% 42
2023
Q4
$37.8M Buy
+265,000
New +$35.3M 0.81% 49
2023
Q3
Sell
-565,000
Closed -$89.9M 86
2023
Q2
$89.9M Buy
565,000
+100,000
+22% +$16.1M 2.09% 9
2023
Q1
$73.6M Buy
465,000
+75,000
+19% +$11.2M 1.86% 12
2022
Q4
$54.7M Sell
390,000
-150,000
-28% -$21.3M 2.2% 16
2022
Q3
$69.3M Buy
540,000
+15,000
+3% +$2.16M 2.51% 7
2022
Q2
$74M Sell
525,000
-175,000
-25% -$25M 1.88% 12
2022
Q1
$97.3M Buy
700,000
+442,082
+171% +$67.7M 2.48% 7
2021
Q4
$45M Buy
+257,918
New +$43M 0.66% 63
2021
Q3
Sell
-365,000
Closed -$65.7M 124
2021
Q2
$65.7M Buy
+365,000
New +$66.6M 1.47% 22

Other funds holding CLX

Candlestick Capital Management's CLX Position: Q3 2024 in Review

Candlestick Capital Management sold out of Clorox (CLX) in Q3 2024, closing a stake of 500,000 shares — an estimated $68.2M sold.

Candlestick Capital Management first reported a position in CLX in Q2 2021 and held it in 11 quarters. The position peaked at $97.3M in Q1 2022. 1,152 funds tracked by Wall St. Rank hold CLX as of Q3 2024.

  • Candlestick Capital Management reported no remaining Clorox position as of Q3 2024 after selling out during the quarter.
  • Candlestick Capital Management sold 500,000 Clorox shares in Q3 2024, an estimated $68.2M.
  • Candlestick Capital Management first reported a position in Clorox in Q2 2021 and held it in 11 quarters.
  • Candlestick Capital Management's Clorox position peaked at $97.3M in Q1 2022.
  • 1,152 funds tracked by Wall St. Rank held Clorox as of Q3 2024.

Based on Candlestick Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.